Equities analysts expect MedEquities Realty Trust (NYSE:MRT) to post earnings of $0.30 per share for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for MedEquities Realty Trust’s earnings, with the lowest EPS estimate coming in at $0.29 and the highest estimate coming in at $0.31. MedEquities Realty Trust reported earnings of $0.27 per share during the same quarter last year, which suggests a positive year over year growth rate of 11.1%. The business is scheduled to report its next earnings results on Tuesday, August 14th.
On average, analysts expect that MedEquities Realty Trust will report full year earnings of $1.20 per share for the current financial year, with EPS estimates ranging from $1.19 to $1.22. For the next fiscal year, analysts forecast that the company will report earnings of $1.24 per share, with EPS estimates ranging from $1.22 to $1.27. Zacks’ earnings per share calculations are an average based on a survey of research analysts that that provide coverage for MedEquities Realty Trust.
Get MedEquities Realty Trust alerts:
MedEquities Realty Trust (NYSE:MRT) last announced its quarterly earnings data on Thursday, May 10th. The financial services provider reported $0.16 EPS for the quarter, missing the Zacks’ consensus estimate of $0.30 by ($0.14). MedEquities Realty Trust had a net margin of 34.63% and a return on equity of 6.17%. The firm had revenue of $16.72 million during the quarter, compared to analysts’ expectations of $16.41 million.
A number of brokerages have commented on MRT. B. Riley set a $13.00 price objective on shares of MedEquities Realty Trust and gave the company a “buy” rating in a research report on Monday. KeyCorp dropped their price objective on shares of MedEquities Realty Trust from $13.00 to $12.00 and set an “overweight” rating on the stock in a research report on Monday, April 16th. ValuEngine downgraded shares of MedEquities Realty Trust from a “hold” rating to a “sell” rating in a research report on Wednesday, May 2nd. Cantor Fitzgerald reissued a “buy” rating and issued a $14.00 price objective on shares of MedEquities Realty Trust in a research report on Wednesday, February 21st. Finally, Citigroup lowered their target price on shares of MedEquities Realty Trust from $12.00 to $10.00 and set a “neutral” rating for the company in a report on Thursday, March 1st. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and four have assigned a buy rating to the company. The stock has an average rating of “Hold” and an average price target of $12.43.
Shares of NYSE:MRT traded up $0.07 during trading hours on Friday, reaching $10.39. The stock had a trading volume of 126,255 shares, compared to its average volume of 156,942. MedEquities Realty Trust has a 1 year low of $10.27 and a 1 year high of $10.43. The company has a market cap of $326.84 million, a PE ratio of 9.11 and a beta of -0.18.
The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 5th. Stockholders of record on Tuesday, May 22nd will be issued a $0.21 dividend. This represents a $0.84 annualized dividend and a dividend yield of 8.08%. The ex-dividend date of this dividend is Monday, May 21st. MedEquities Realty Trust’s payout ratio is 73.68%.
In other news, Director Bluemountain Capital Managemen sold 17,674 shares of the company’s stock in a transaction on Friday, May 4th. The shares were sold at an average price of $10.16, for a total value of $179,567.84. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In the last 90 days, insiders sold 235,786 shares of company stock valued at $2,435,627. Company insiders own 2.50% of the company’s stock.
Several institutional investors have recently modified their holdings of the company. American Century Companies Inc. boosted its stake in MedEquities Realty Trust by 22.3% during the 4th quarter. American Century Companies Inc. now owns 2,111,333 shares of the financial services provider’s stock worth $23,689,000 after purchasing an additional 385,125 shares during the period. BlackRock Inc. boosted its stake in MedEquities Realty Trust by 2.3% during the 4th quarter. BlackRock Inc. now owns 1,424,525 shares of the financial services provider’s stock worth $15,984,000 after purchasing an additional 32,289 shares during the period. Russell Investments Group Ltd. boosted its stake in MedEquities Realty Trust by 10.8% during the 1st quarter. Russell Investments Group Ltd. now owns 1,165,213 shares of the financial services provider’s stock worth $12,246,000 after purchasing an additional 113,799 shares during the period. Northpointe Capital LLC boosted its stake in MedEquities Realty Trust by 1.6% during the 4th quarter. Northpointe Capital LLC now owns 863,411 shares of the financial services provider’s stock worth $9,687,000 after purchasing an additional 13,444 shares during the period. Finally, Schwab Charles Investment Management Inc. boosted its stake in MedEquities Realty Trust by 69.2% during the 4th quarter. Schwab Charles Investment Management Inc. now owns 776,946 shares of the financial services provider’s stock worth $8,718,000 after purchasing an additional 317,829 shares during the period. Institutional investors and hedge funds own 89.09% of the company’s stock.
MedEquities Realty Trust Company Profile
MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios.
Get a free copy of the Zacks research report on MedEquities Realty Trust (MRT)
For more information about research offerings from Zacks Investment Research, visit Zacks.com